Related Experiment Video

Updated: Aug 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Children with hepatitis C

Girish Subba Rao1, Jean Pappas Molleston

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, 702 Barnhill Drive, Room ROC 4210, Indianapolis, IN 46202-5225, USA.

Current Gastroenterology Reports
|February 11, 2005
PubMed

Insights

Hepatitis C affects many children globally, often acquired vertically. Antiviral treatments show promise, but further research is crucial for managing long-term liver disease risks.

Area of Science:

  • Pediatrics
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection impacts numerous children worldwide.
  • Primary transmission routes include vertical transmission and parenteral exposure.
  • While often asymptomatic in childhood, HCV can lead to significant liver inflammation and fibrosis.

Purpose of the Study:

  • To review the current understanding of Hepatitis C in pediatric populations.
  • To assess the efficacy and tolerability of antiviral therapies in children.
  • To highlight the need for continued research into HCV's natural history and treatment in children.

Main Methods:

  • Review of existing literature on pediatric Hepatitis C.
  • Analysis of clinical trial data for antiviral therapies.
  • Evaluation of long-term outcomes and disease progression.

Main Results:

  • Interferon and ribavirin therapies demonstrate effectiveness in approximately 50% of treated children.
  • Pediatric patients generally exhibit good tolerance to antiviral treatments.
  • Hepatitis C infection in children can progress to severe liver conditions.

Conclusions:

  • Antiviral therapy offers a viable treatment option for pediatric Hepatitis C.
  • Early intervention and ongoing research are essential for mitigating severe long-term consequences.
  • Further studies are needed to fully elucidate the natural history and optimize treatment strategies for childhood HCV.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...